☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Innovent Biologics
Innovent Reports Results from the P-III (RESTORE-1) Study of IBI311 for the Treatment of Thyroid Eye Disease
February 20, 2024
Innovent Biologics Enters into a Collaboration Agreement with Xuanzhu Biopharma to Study and Supply Tyvyt with KM-501 for Solid Tu...
December 28, 2023
Innovent Biologics Signs an Expanded Agreement with Synaffix for the Development of Antibody Drug Conjugates (ADCs)
December 7, 2023
Innovent Report Results of Dual Regimen in P-III ORIENT-32 Study as 1L Therapy for Advanced HCC
September 28, 2020
Insights+ Key Biosimilars Events of January 2020
February 14, 2020
PharmaShots Weekly Snapshot (January 13-17, 2020)
January 20, 2020
Load more...
Back to Home